The Inspire ANTI SNORING Implant is really a medical device that’s implanted into the body for the treating snoring and obstructive anti snoring (OSA) syndrome.
Obstructive ANTI SNORING Syndrome
Obstructive sleep apnea syndrome is a disease caused by relapsing episodes of sleep apnea. This is usually a condition where breathing stops for more than 10 seconds, during which oxygen saturation in the blood is reduced by more than 4%.
OSA syndrome occurs during sleep, when the muscles of upper airways relax, evoking the obstruction of the respiratory tract. This results in deterioration of blood oxygenation and provokes short unconscious wake-up episodes through the entire night. An unhealthy pattern of sleep places pressure on the body, causing increased blood pressure and development of severe diseases. The diseases due to OSA could be physical, such as hypertension, myocardium infarction and stroke. They might also be mental, including depression, chronic fatigue syndrome, lack of memory and concentration.
Before any treatment, a sleep study or perhaps a polysomnography is needed. The polysomnography calculates the apnea index, which is the frequency of apnea episodes during one hour of sleep and determines the severe nature of the disease. The apnea index is known as significant if there are more than 20 apnea episodes per hour, regardless of the presence or lack of clinical symptoms.
The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy is not for everyone as many folks find it uncomfortable to sleep with the mask on the facial skin and the device itself can be loud, especially since it commonly sits near the head. Only 25% of patients may use CPAP-therapy for a long period of time.
Therefore, recently Inspire Medical Systems Inc. has come up with a very effective solution with the Inspire Sleep Apnea Implant.
How The Inspire Sleep Apnea Implant Works
The Inspire Sleep Apnea Implant is a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately a decade.
The main unit of this device is placed under the skin, on the front right side of the chest also it monitors the phase of breathing. The other electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens top of the airways and allows the tongue to stick out, and helps keep the airways open while asleep.
As well as the two electrodes, this device also includes a handy small remote switch, that actually turns on the device before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating during the active phase of the day, when a person needs physiological narrowing of the larynx and tongue movements for these procedures.
The patient may feel light involuntary contractions of the larynx, or tongue movements during initial use of these devices. These movements do not cause pain, instead just a minor discomfort. ufabet These unpleasant effects disappear following the first few uses of these devices.
Generally, the implant should be checked 1 or 2 2 times each year. However, with respect to the situation, an Inspire therapy-trained doctor may consult patients more or less often.
The Inspire ANTI SNORING Implant is only ideal for:
Patients who are more than 22 years old.
Patients who’ve been identified as having moderate or severe obstructive anti snoring syndrome.
Patients having an apnea index in the range of 20 to 65.
Patients who are not comfortable with using CPAP therapy or did not work.
Patients with a body mass index of significantly less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
An individual with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire ANTI SNORING Implant could potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive anti snoring syndrome. A report by Dr. Ryan J. et al. has shown that after implantation of the Inspire ANTI SNORING Implant, snoring is greatly decreased. A share of “no” or “soft” snoring changed from 22% at beginning of the treatment to 88% at 12 months and 91% at 24 months following the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the analysis reported a nightly use of this therapy for five years. Therefore, it is evident that method is impressive and easy to use!